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Purpose: To show feasibility of the covered endovascular repair of the aortic 
bifurcation (CERAB) technique in conjunction with chimney grafts in aortic side 
branches for complex aortoiliac occlusive disease.
Methods: Two European centers and one facility located in New Zealand par-
ticipated in a retrospective observational study that enrolled 14 consecutive 
patients (mean age 61.2 ± 8.9 years; 11 men) treated with CERAB in conjunction 
with chimney graft(s) between December 2012 and May 2015. Indications for 
treatment included disabling claudication in 9 and critical limb ischemia in 5. 
Lesions were classified as Trans Atlantic Inter-Society Consensus II B (n = 1), C 
(n = 1), or D (n = 12).
Results: A total of 15 chimney grafts were used to perfuse the inferior mesen-
teric artery (n = 8), the right renal artery (n = 4), and the left renal artery (n = 3). 
Technical success was achieved in all cases. Procedural complications included 
5 unintended dissections and 1 vessel thrombosis, all of which were success-
fully treated intraoperatively. Five patients developed access-site hematoma/
ecchymosis (3 at the brachial access). Mean follow-up was 12 months (range 
6–24) without death or loss to follow-up. One patient suffered occlusion of a 
CERAB limb and an IMA chimney graft; the former was recanalized, but the 
IMA graft was not; there were no signs of bowel ischemia. Ankle-brachial indi-
ces significantly increased from 0.54 (range 0.47–0.60) preoperatively to 0.97 
(range 0.90–1.00) in 11 patients examined at 12 months, and all patients had 
an improvement in the Rutherford category. All CERAB limbs, including the one 
recanalized, were patent at the most recent follow-up, as were 14 of 15 chimney 
grafts.
Conclusion: Chimney-CERAB is technically feasible and may offer an alternative 
to open surgery for complex aortoiliac occlusive disease. Further prospective 





Endovascular techniques continue to evolve and are broadly applied to a variety of vas-
cular diseases, including aortoiliac occlusive disease (AIOD). For severe AIOD, the gold 
standard is still open surgery, typically using an aortobifemoral bypass graft, but this 
procedure has considerable morbidity and mortality.1 Endovascular treatment for Trans 
Atlantic Inter-Society Consensus (TASC) C and D lesions involving the aortic bifurcation 
remains a matter of debate, although the efficacy has been shown.2 The decision 
largely depends on patient characteristics and physician preference and experience. 
The covered endovascular repair of the aortic bifurcation (CERAB) technique offers 
an endovascular alternative for TASC C/D lesions involving the aortic bifurcation.2 This 
relatively new technique uses 3 balloon-expandable covered stents to create an aortic 
neo-bifurcation by placing one flared covered stent in the distal aorta and inserting the 
proximal ends of the other covered stents placed in the common iliac arteries (CIA). 
When indicated, the limbs can be extended using additional covered stents. Initial 
results have been promising, with 1-year primary and secondary patency rates of 87 % 
and 95 %, respectively, in a group of patients with 95 % TASC II C/D lesions.3
The applicability of the CERAB technique may be limited by the extent or location 
of the occlusive lesion. One potential problem is a lesion involving a patent inferior 
mesenteric artery (IMA), which cannot always be sacrificed without an imminent risk 
of bowel ischemia, especially with a concomitant lesion in the superior mesenteric 
artery (SMA) and/or celiac artery (CA). Data on the consequences of covering the 
IMA and the risk of developing complications are lacking for endovascular treat-
ment, but reports in open surgery suggest a decrease in the incidence of ischemic 
colitis when the IMA is re-implanted, especially in older patients.4,5 Also, in case of 
bilateral internal iliac artery (IIA) occlusion, the IMA may serve as a collateral vessel, 
and increased bowel ischemia and spinal cord ischemia rates have been reported 
in endovascular aneurysm repair in this patient subgroup.6,7 In even more extensive 
disease, the proximal border of the lesion can extend up to, or involve, the renal 
artery ostia. In these cases, coverage of a renal artery is usually not an attractive op-
tion. In addition, the placement of the proximal aortic stent in such a diseased aortic 
segment may cause thromboembolic events and subsequent loss of renal function.
The chimney or snorkel technique has been successfully applied to extend the 
proximal landing zone in the endovascular treatment of aneurysmal disease.8 
This technique was adapted and implemented with the CERAB technique to 
allow more extensive lesions to be treated by endovascular means while keeping 
the target vessels patent. The aim of this study was to show the feasibility and 
initial results of the CERAB technique in conjunction with chimney grafts for 




study design and Patient sample
Two European centers and one facility located in New Zealand participated in 
a retrospective observational study approved by each center’s ethics commit-
tee according to national guidelines. Fourteen consecutively treated patients 
(mean age 61.2 ± 8.9 years; 11 men) who underwent CERAB in conjunction 
with a chimney graft were treated between December 2012 and May 2015. 
Indication for treatment included disabling claudication (Rutherford category 3) 
in 9 patients and critical limb ischemia (Rutherford category 4) in 5 patients. 
Lesions were classified as TASC II B (n = 1), C (n = 1), or D (n = 12). The majority of 
patients had a distal aortic occlusion with eccentric thrombus extending up to or 
above one or more renovisceral vessel orifices. One patient had previous kissing 
stent placement in both CIAs and presented with an occlusion. Risk factors and 
relevant lesion characteristics are shown in Table 1.













External iliac artery 9/8
Internal iliac artery 5/5




Inferior mesenteric artery 5
Superior mesenteric artery 9





All patients received secondary risk prevention according to local guidelines, and 
patients with disabling claudication were primarily treated with (supervised) walking 
exercise. After clinical evaluation, all patients underwent duplex ultrasound scanning, 
ankle-brachial index (ABI) measurement, and a preoperative assessment using com-
puted tomography angiography (CTA). The CTA images and multiplanar reconstruc-
tions were evaluated on a 3D workstation for procedure planning. The decision to 
treat patients using the chimney- CERAB technique was made on an individual basis.
chimney-cerab Technique
The procedures were performed by vascular surgeons and interventional radiolo-
gists in either a hybrid suite equipped for both interventional radiology and open 
surgical procedures or a surgical theatre using a recent generation mobile C-arm. 
A detailed description of the standard CERAB technique has been previously 
published.1 Briefly, after antibiotic prophylaxis, both common femoral arteries 
were accessed either percutaneously (n = 6) or by surgical cutdown (n = 8), 
along with 1 brachial artery for chimney graft delivery. Heparin (5000 units) 
was administered after sheath insertion. The occluded segment was recanalized 
using regular hydrophilic wires and catheters, and the intended chimney target 
vessel(s) were selectively catheterized via the brachial approach, followed by 
insertion of a 5- to 7-mm balloon-expandable covered stent (Atrium Advanta 
V12; Atrium Maquet Getinge Group, Mijdrecht, the Netherlands). A 12-, 14-, or 
16-mm Atrium Advanta LD-V12 (Atrium Maquet Getinge Group) was then po-
sitioned in the distal aorta and deployed. The chimney graft(s) were positioned 
and deployed. Subsequently, the proximal two-thirds of the aortic LD-V12 stent 
was flared with a 16-mm balloon to adapt to the aortic diameter while balloon(s) 
in the chimney graft(s) were left inflated. Two 8- or 9-mm Advanta V12 covered 
stents were placed in the distal third of the aortic cuff in a kissing-stent configu-
ration within the CIAs and simultaneously inflated, simulating a new bifurcation 
with the hemodynamic aspects of a flow divider. If required, these 2 limbs were 
extended using additional covered stents.
All patients received dual antiplatelet therapy for at least 6 months postop-
eratively (clopidogrel and either acetylsalicylic acid or carbasalate calcium). 
Examples are provided of chimney-CERAB procedures in the IMA (Figure 1) and 
renal arteries (Figure 2). Follow-up consisted of clinic visits with monitoring of 
renal function and serial duplex ultrasound scanning with ABI measurement at 




definitions and statistical analysis
Technical success was defined as successful placement of both the CERAB 
endografts and the chimney graft(s), restoring blood flow with < 30 % residual 
stenosis on completion angiography. Clinical improvement referred to hemody-
namic improvement (ABI increase of at least 0.10) combined with symptomatic 
improvement (at least 1 Rutherford category).
Restenosis was defined as a lesion with a peak systolic velocity ratio > 2.5 as 
measured in the endograft and proximal or distal to the endograft or an angio-
graphic diameter reduction >  50 %. Previously described duplex criteria were 
used for the IMA.9
Figure 1. Chimney CERAB procedure (IMA). Peri-operative fluoroscopy and angiography 
images showing (A) primary angiography; the distal aorta is occluded. The IMA is patent 
and quite large in diameter. Patient also has a left renal artery stenosis. (B) Both external and 
common iliac arteries are recanalized and the IMA is selectively cannulated from the upper 
access site. (C) Pre-dilation of the ‘neo-bifurcation’ with the chimney covered stent in situ 
(not yet deployed). (D) Angiography after deployment of CERAB and IMA Chimney, all pat-




Continuous variables are described as mean ± standard deviation or median and 
interquartile range (IQR) if a Kolmogorov-Smirnov test of normality indicated 
nonparametric data. Differences between ABI values were tested using a paired 
t test. A 2-sided p < 0.05 was considered the threshold of significance. Data 
analysis was performed using SPSS statistics (version 20.0; IBM Corporation, 
Somers, NY, USA).
resulTs
All lesions were recanalized, all target vessels were cannulated, and the proce-
dures were successfully completed in all cases. A total of 15 chimney grafts were 
used (8 IMAs, 4 right renal arteries, 3 left renal arteries). All target chimney target 
vessels were patent preoperatively, but 2 IMAs had a preexisting stenosis (50 % 
Figure 2. Chimney CERAB procedure (bilateral renal arteries). Peri-operative fluoroscopy and 
angiography images showing (A) primary angiography; the distal aorta is occluded, including 
the IMA, up to the level of the patent left and right renal ostia. (B) Angiography with bilateral 
chimney covered stents and wires to both external iliac arteries in situ. (C) Fluoroscopy after 
placement of the bilateral chimney covered stents with the proximal aortic covered stent in 
situ (not yet deployed). (D) The proximal aortic covered stent is deployed under fluoroscopic 
guidance with both chimney covered stents in situ with balloons inflated. (D) Final angiog-
raphy showing a patent SMA and bilateral renal arteries with runoff to the bilateral CERAB 
limbs without signs of residual stenosis.
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and 70 %, respectively). None of the patients who underwent IMA chimney 
grafting had concomitant CA or SMA stenosis or occlusion. There was, however, 
involvement of the IIAs in 4 patients: bilateral IIA stenosis (n = 1), 1 occluded and 
1 stenosed IIA (n = 2), and bilateral occluded IIAs (n = 1). In the majority of cases 
(n = 10), a 12-mm Advanta LD-V12 was used as the aortic stent; in the other 
cases, a 14-mm (n = 3) or a 16-mm stent were used. The distal landing zone 
was either the CIA (9/28 on the right, 10/28 on the left) or the EIA (5/28 on the 
right, 4/28 on the left). In 3 iliac arteries, the covered stent was distally extended 
with an uncovered self-expanding stent. Access sites were typically closed using 
a closure device (n = 12), but compression (n = 1) and suturing (n = 1) were used 
in individual cases.
Median procedure time was 155 minutes (IQR 100–182) with a median contrast 
dose of 150 mL (IQR 140–180). Intraoperative complications included 5 unin-
tended dissections (treated with either prolonged dilation or stent extension) 
and nonocclusive thrombosis of a 14-mm V12 aortic stent (treated with throm-
bolysis), all of which were successfully resolved during the index procedure. Five 
patients developed access site hematoma/ecchymosis (3 at the brachial access). 
There were no 30-day major adverse events or mortality.
Mean follow-up was 12 months (range 6–24), and there was no death or loss 
to follow-up. One serious adverse event occurred 7 months after the primary 
procedure. The patient suffered occlusion of a right CERAB limb and the single 
chimney graft (IMA). The iliac limb was successfully treated with catheter-directed 
thrombolysis, but no attempt was made to recanalize the side branch; there 
were no signs of subsequent bowel ischemia, and recovery was uneventful. 
There were no additional complications after 1 year. All CERAB limbs, including 
the one recanalized, were patent at the most recent follow-up.
ABIs significantly increased from 0.54 (range 0.47–0.60) preoperatively to 0.94 
(range 0.87–1.00) at 1 month and 0.97 (range 0.90–1.00) in the 11 patients 
examined at 12 months. All patients showed an improvement in Rutherford 
category. At 12-month follow-up, 9 patients had no claudication, 1 patient had 
mild claudication on exertion, and 1 patient had moderate claudication with a 
walking distance > 200 m. Fourteen of 15 chimney grafts implanted were patent 





This case series shows that the chimney-CERAB technique is feasible and can 
be performed with high technical success, acceptable morbidity, and midterm 
clinical improvement. Therefore, the chimney-CERAB technique may offer an 
attractive alternative treatment for complex AIOD that was previously not ap-
propriate for endovascular techniques. This could be of importance especially 
for those patients with extensive comorbid conditions who are deemed unfit 
for major surgery, which in these cases would involve not only aortobifemoral 
bypass grafting but also visceral vessel reimplantation or bypass.
The high number of intraoperative complications should be considered in context 
with the disease. In AIOD, subintimal recanalization and subsequent creation of a 
dissection plane is observed frequently. It was decided to report the 5 dissections 
to give a representative view of the technical difficulty associated with this pro-
cedure. As stated, all of these were addressed intraoperatively and did not cause 
the patient any harm. The postoperative complications were confined to access 
site hematoma and ecchymosis only, the majority related to the upper access site.
Thromboembolic events are considered potentially severe complications and tend 
to occur in complex lesions with more extensive atherosclerotic plaques and/or 
thrombus. Prophylactic measures are debatable but widely used.10 Despite intra-
operative antithrombotic therapy, one vessel in our series occluded during the 
procedure. In this case there was an occluded distal aorta with thrombus extend-
ing up to the renal arteries with a patent IMA. A nonocclusive thrombus in the 
14-mm aortic stent was observed, possibly due to dislodgement of thrombus. 
Thrombolysis was initiated intraoperatively with good result. While no clinical 
signs of distal thromboembolic events were observed, one patient did present 
with an occluded CERAB limb and chimney graft 7 months postoperatively.
The current TASC guidelines11 recommend that endovascular treatment be re-
served for less complex TASC A/B lesions. Increasing evidence indicates that the 
more complex TASC C/D lesions can be treated using endovascular techniques 
with satisfying results. The recent report of the 24-month results from the Bravis-
simo registry12 concluded that endovascular treatment may be the preferred first 
treatment option for all TASC classes because high levels of patency were found 
irrespective of the lesion classification or length (24-month patency of 91.9 % 
for TASC C and 84.8 % for TASC D).10 In this study,12 higher patency rates were 
achieved using covered stents compared to bare metal stents, which is in accord 
with the prospective randomized COBEST trial13 that reported superior results of 
covered stents in TASC C/D lesions.
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Experience using the CERAB technique is still limited. Although results from a 
dual-center cohort study,3 including consecutive patients from the first-in-man 
trial, are encouraging, the conclusions must be interpreted with caution, and 
further studies are indicated. A comparison with the literature is complicated by 
the differences in patient and lesion characteristics and by the potential learning 
curve effect included in that study. When introducing a new technique, selection 
bias is bound to occur. In the current series, patients treated had mild comorbidi-
ties and were relatively young (mean age 61 years), both of which may positively 
influence outcome.
Overstenting of renovisceral arteries is generally not well tolerated, particularly 
the renal artery, though an ancillary renal artery may be sacrificed if there is 
adequate kidney function. An exception is the IMA, which is commonly covered 
in endovascular aneurysm treatment. In AIOD, preservation of the IMA may be 
of more importance since quite often one or more collateral vascular beds will 
be affected by significant atherosclerosis. Although not supported by scientific 
evidence, it seems to be wise to preserve the IMA when it has a significant 
diameter (≥  5 mm) and presents in conjunction with a significant stenosis or 
occlusion of the SMA or CA. In case of eccentric thrombus extending to or 
above the renal arteries or even more proximal to the SMA or CA, it is the 
authors’ belief that this is always an indication for chimney grafts unless renal 
function is already absent. Current literature suggests a possible benefit of IMA 
preservation, especially in older patients with increased operative blood loss.14 
This is based on research in IMA reimplantation during open abdominal aortic 
aneurysm repair.
Developments in endovascular techniques over the past 2 decades have given 
rise to a whole new arsenal of treatment options, all of which are far less invasive 
then their respective open surgical counterparts. Astute patient selection is vital, 
and this is particularly true for endovascular treatment. Endovascular techniques 
such as chimney-CERAB may be reserved for those patients unfit for surgery. 
However, particularly in the young patients, it might be a valid argument to 
preserve the surgical options and reduce the risk of potentially harmful long-
term complications such as adhesions and incisional hernia. Further research is 
needed to identify potential risk factors and patients who will benefit most from 
chimney grafts during CERAB.
Patients undergoing CERAB with chimney grafts should be treated in centers 
where there is a broad experience with endovascular techniques in general and 
CERAB in particular. Preoperative planning is paramount, both to achieve opti-




A small native aorta may limit the use of chimney-CERAB; however, the native 
aorta is usually 20 to 25 mm, which is sufficient to host the body and chimney 
grafts. In the current study, this problem was not encountered, but preoperative 
planning should take this into consideration. Cost-effectiveness of this novel 
technique also warrants further attention when long-term data are available.
limitations
All patients were selected and treated by physicians with extensive experience in 
endovascular techniques and CERAB; therefore, the results might not be achieved 
in general practice. Since this is a proof of concept study, no comparison was 
made between the presented treatment and gold standard open surgery. The 
midterm outcomes are encouraging, but the numbers are small. Longer follow-
up in series with larger sample sizes is needed to strengthen these findings.
conclusion
Based on the high technical success, acceptable morbidity, and midterm clini-
cal improvement seen in this study, chimney-CERAB appears to offer a feasible 
alternative to open surgery for complex (TASC C/D) aortoiliac occlusive disease. 
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